Maheshwari Akhil, Kurundkar Ashish R, Shaik Sadiq S, Kelly David R, Hartman Yolanda, Zhang Wei, Dimmitt Reed, Saeed Shehzad, Randolph David A, Aprahamian Charles, Datta Geeta, Ohls Robin K
Pediatrics/Neonatology, Univ. of Alabama at Birmingham, VH648C, 1670 Univ. Blvd., Birmingham, AL 35294, USA.
Am J Physiol Gastrointest Liver Physiol. 2009 Jul;297(1):G1-G10. doi: 10.1152/ajpgi.90730.2008. Epub 2009 May 14.
Macrophages are first seen in the fetal intestine at 11-12 wk and rapidly increase in number during the 12- to 22-wk period of gestation. The development of macrophage populations in the fetal intestine precedes the appearance of lymphocytes and neutrophils and does not require the presence of dietary or microbial antigens. In this study, we investigated the role of chemerin, a recently discovered, relatively selective chemoattractant for macrophages, in the recruitment of macrophage precursors to the fetal intestine. Chemerin mRNA/protein expression was measured in jejunoileal tissue from 10- to 24-wk human fetuses, neonates operated for intestinal obstruction, and adults undergoing bariatric surgery. The expression of chemerin in intestinal epithelial cells (IECs) was confirmed by using cultured primary IECs and IEC-like cell lines in vitro. The regulatory mechanisms involved in chemerin expression were investigated by in silico and immunolocalization techniques. IECs in the fetal, but not mature, intestine express chemerin. Chemerin expression peaked in the fetal intestine at 20-24 wk and then decreased to original low levels by full term. During the 10- to 24-wk period, chemerin accounted for most of the macrophage chemotactic activity of cultured fetal IECs. The maturational changes in chemerin expression correlated with the expression of retinoic acid receptor-beta in the intestine. Chemerin is an important mediator of epithelial-macrophage cross talk in the fetal/premature, but not in the mature, intestine. Understanding the regulation of the gut macrophage pool is an important step in development of novel strategies to boost mucosal immunity in premature infants and other patient populations at risk of microbial translocation.
巨噬细胞最早在妊娠11 - 12周时出现在胎儿肠道中,并在妊娠12至22周期间数量迅速增加。胎儿肠道中巨噬细胞群体的发育先于淋巴细胞和中性粒细胞的出现,且不需要饮食或微生物抗原的存在。在本研究中,我们调查了chemerin(一种最近发现的、对巨噬细胞具有相对选择性的趋化因子)在巨噬细胞前体募集至胎儿肠道过程中的作用。我们检测了10至24周龄人类胎儿、因肠梗阻接受手术的新生儿以及接受减肥手术的成年人空回肠组织中chemerin mRNA/蛋白的表达。通过体外培养原代肠上皮细胞(IECs)和IEC样细胞系,证实了chemerin在肠上皮细胞中的表达。采用计算机模拟和免疫定位技术研究了chemerin表达所涉及的调控机制。胎儿肠道而非成熟肠道中的IECs表达chemerin。chemerin表达在胎儿肠道中于20 - 24周达到峰值,然后在足月时降至原始低水平。在10至24周期间,chemerin占培养的胎儿IECs巨噬细胞趋化活性的大部分。chemerin表达的成熟变化与肠道中视黄酸受体β的表达相关。Chemerin是胎儿/早产儿肠道而非成熟肠道中上皮 - 巨噬细胞相互作用的重要介质。了解肠道巨噬细胞池的调控是开发新策略以增强早产儿和其他有微生物易位风险患者群体黏膜免疫的重要一步。